Sussex Blood Cancer Research's Avatar

Sussex Blood Cancer Research

@sussexbcr

A network of research groups across the University of Sussex, Brighton & Sussex Medical School and University Hospitals Sussex NHS trust investigating the causes of blood cancers, and developing new therapeutic strategies to improve patient survival.

43
Followers
16
Following
26
Posts
11.01.2025
Joined
Posts Following

Latest posts by Sussex Blood Cancer Research @sussexbcr

Network opportunity!

3 year @cancerresearchuk.org funded Research Fellow post in the @rhysmorganlab.bsky.social in @biochembiomeduos.bsky.social alongside David Palmer in @bsmsmedschool.bsky.social working on RUNX1 mutations in CML.

Deadline Mar 8th. ApplyπŸ‘‡for mid-Mar interviews and May start date

17.02.2026 10:04 πŸ‘ 2 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Preview
Research Fellow in Biochemistry & Biomedicine Ref: 43149 (Fixed Term) - Job page - University of Sussex Job Search

We're hiring a new 3 yr postdoc!

Join us for an exciting new CRUK funded project targeting RUNX1 mutations in CML in a highly supportive environment within @sussexbcr.bsky.social @biochembiomeduos.bsky.social @sussexcancer.org

ApplyπŸ‘‡, advert closes 8th March.

jobs.sussex.ac.uk/job/4fee4e78...

09.02.2026 14:04 πŸ‘ 7 πŸ” 3 πŸ’¬ 0 πŸ“Œ 2

Good news Friday!

Congratulations to @rhysmorganlab.bsky.social in @biochembiomeduos.bsky.social @sussex.ac.uk who have received their first funding from @cancerresearchuk.org with @uhsussex.bsky.social Clinical Fellow Dr David Palmer to progress their studies targeting RUNX1 mutations in CML. πŸ‘Š

06.02.2026 14:54 πŸ‘ 5 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0

Beyond pleased to announce our lab has secured its first @cancerresearchuk.org funding with an Early Detection & Diagnosis Project Award titled:

'Detecting and targeting translation inhibitor sensitive RUNX1 mutations in Chronic Myeloid Leukaemia'

1/5

www.cancerresearchuk.org/for-research...

02.02.2026 08:01 πŸ‘ 10 πŸ” 2 πŸ’¬ 2 πŸ“Œ 1

πŸ—žοΈ New pre-print postedπŸ—žοΈ

Dr Okan Sevim from @rhysmorganlab.bsky.social @biochembiomeduos.bsky.social @sussex.ac.uk begins the publication of his doctoral work examining Wnt/B-catenin crosstalk with the RNA Binding Protein LIN28B and its potential for dual drug targeting in acute myeloid leukaemia. πŸ‘

30.01.2026 16:46 πŸ‘ 2 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Dual targeting a LIN28B:Ξ²-catenin axis in acute myeloid leukaemia Wnt/Ξ²-catenin signalling is dysregulated across several haematological malignancies, including acute myeloid leukaemia (AML), where is lacks effective targeting strategies. Previously, we discovered that Ξ²-catenin interacts with several RNA-binding proteins (RBP), and binds mRNA indirectly, indicating contributions to the post-transcriptional landscape of leukaemia cells. Here, we found the most frequent RBP-binding motif amongst Ξ²-catenin-bound mRNAs was the GGAG motif targeted by the oncofoetal expressed miRNA-regulating RBP LIN28B. We detected the Ξ²-catenin:LIN28B interaction in lymphoid and myeloid cell lines, and primary human CD34⁺ fetal liver-derived haematopoietic stem cells. LIN28B positively regulated Wnt signalling capacity by regulating LEF1 expression through a post-transcriptional mechanism requiring the let7 miRNA axis. Further miRNA sequencing of Ξ²-catenin- and LIN28B-depleted myeloid cells revealed both potential cooperative and antagonistic function in miRNA regulation. Finally, dual-targeting both Ξ²-catenin and LIN28B through either genetic or pharmacological means preferentially killed AML cells. These data reveal a potential novel synthetically lethal relationship in AML which could be exploited in the rare AML subsets where LIN28B expression becomes reactivated ### Competing Interest Statement The authors have declared no competing interest. Kay Kendall Leukaemia Fund, https://ror.org/03j2wfg84, KKL1051, KKL1446 Leukaemia & Myeloma Research UK, 4-5/06.21R ChildrenΒ’s Cancer & Leukaemia Group, CCLGA 2023 16 Morgan Republic of TΓΌrkiye Ministry of National Education

Very pleased to share our latest pre-print which showcases the incredible hard work and skill of Dr Okan Sevim.

Our continued exploration of Ξ²-catenin's contribution to the post transcriptional landscape of blood cells led us to a LIN28B interaction.

1/7

www.biorxiv.org/content/10.6...

28.01.2026 08:52 πŸ‘ 10 πŸ” 3 πŸ’¬ 2 πŸ“Œ 2

πŸ””New network opportunity!πŸ””

Prof @mitchell.science at @bsmsmedschool.bsky.social is advertising a new 3yr @leukaemiauk.bsky.social funded PDRA using mechanistic models to identify B-cell lymphoma therapeutic vulnerabilities.

Expected start date: April’26

ApplyπŸ‘‡by 01/03/2026 and join Sussex BCR!

30.01.2026 16:33 πŸ‘ 3 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0
Preview
We are recruiting a postdoctoral research fellow. | Mitchell Lab We're excited to announce that we're looking for a postdoctoral research to join our team!

We’re excited to announce that we’re looking for a postdoctoral research to join our team!
This is an opportunity to lead an exciting project aiming to push the boundaries of personalised medicine through integrating data, simulation and lab experiments.

Plz share

mitchell.science/talk/we-are-...

28.01.2026 10:58 πŸ‘ 5 πŸ” 5 πŸ’¬ 0 πŸ“Œ 1

Many thanks to all the co-authors at @sussexbcr.bsky.social @bsmsmedschool.bsky.social
@sussex.ac.uk @sussexcancer.org @biochembiomeduos.bsky.social @ox.ac.uk who contributed to the study, funders for kindly supporting our work, and all our patients who selflessly donate samples for research.

7/7

28.01.2026 08:52 πŸ‘ 2 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0

We now have a LinkedIn page!

Please follow for the latest updates on research funding, publications, events, scientific/clinical discoveries and job vacancies!

www.linkedin.com/in/sussex-bl...

09.01.2026 15:22 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0

Happy new year from Sussex Blood Cancer Research!

If you’re an ambitious haematology scientist/clinician seeking Fellowships in 2026 to establish your own research lab why not consider @sussex.ac.uk Life Sciences as your host.

Information, support and policy πŸ‘‡πŸ‘‡

www.sussex.ac.uk/webteam/gate...

02.01.2026 15:09 πŸ‘ 2 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0
Preview
Sussex Blood Cancer Research progress in 2025 β€” Sussex Cancer Research Centre Over the past year the Sussex Blood Cancer Research Group has marked a period of progress, reflected across funding success, scientific output and growing research capacity. Colleagues secured a stron...

As 2025 draws to a close, and we sign off for the Xmas New Year break, with @sussexcancer.org we review another great year for the Sussex Blood Cancer Research Network.

With more exciting news to announce soon, here’s to a pleasant and fruitful 2026 πŸ₯‚

sussexcancer.org/news/sussex-...

22.12.2025 16:32 πŸ‘ 2 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0

Many thanks to all co-authors at @sussexbcr.bsky.social @bsmsmedschool.bsky.social @sussex.ac.uk @sussexcancer.org @biochembiomeduos.bsky.social and beyond who contributed to the study, funders for kindly supporting our work, and all our patients who selflessly donate samples for research.

19.12.2025 14:22 πŸ‘ 1 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Preview
Reprogramming the Bone Marrow Niche: The Persistent Impact of AML Blasts on Stromal Cells and Macrophages at Brighton & Sussex Medical School on FindAPhD.com PhD Project - Reprogramming the Bone Marrow Niche: The Persistent Impact of AML Blasts on Stromal Cells and Macrophages at Brighton & Sussex Medical School, listed on FindAPhD.com

πŸŽ“Network PhD Opportunity!πŸ”¬

New project in Dr Fabio Simoes’ group in @bsmsmedschool.bsky.social with Oct 2026 start examining the role of the bone marrow niche in AML disease biology.

3-year funding covering tuition fees (home rate) deadline Jan 30th 2026. Apply πŸ‘‡

www.findaphd.com/phds/project...

19.12.2025 14:53 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0

πŸ“– Network pre-print notification!πŸ“„

New pre-print posted from @rhysmorganlab.bsky.social in @sussex.ac.uk led by Drs Hyun Park from @bsmsmedschool.bsky.social and Okan Sevim from @biochembiomeduos.bsky.social revealing a new regulator of leukaemia and stem cell growth; a deadenylase known as TOE1.

19.12.2025 14:30 πŸ‘ 3 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0

Fresh from presentation at @ash.hematology.org #ASH2025, pleased to present our latest pre-print showcasing the hard work of Drs Hyun Park & Okan Sevim. Exploration of b-catenin’s post-transcriptional role has revealed a novel AML cell and stem cell regulator; TOE1.

www.biorxiv.org/content/10.6...

19.12.2025 14:22 πŸ‘ 2 πŸ” 1 πŸ’¬ 1 πŸ“Œ 1
Post image Post image Post image Post image

Stellar job by our Drs Sevim and Goff from @sussex.ac.uk @sussexbcr.bsky.social @sussexcancer.org @biochembiomeduos.bsky.social for presenting their @cclguk.bsky.social LMRUK BSH Sussex Cancer Fund funded ASH achievement award research on the final night of @ash.hematology.org #ASH2025 in OrlandoπŸ‘Š

09.12.2025 14:45 πŸ‘ 2 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Preview
Design, Synthesis, and Biological Evaluation of Efflux-Resistant Imatinib Derivatives Resistance to imatinib, a first-line BCR-ABL1 tyrosine kinase inhibitor for chronic myeloid leukemia, is frequently mediated by drug efflux through P-glycoprotein (P-gp) overexpression. We report the ...

πŸ—žοΈPublication update!πŸ—žοΈ

Congrats @chrispepper68.bsky.social @bsmsmedschool.bsky.social for his new paper in @pubs.acs.org Jnl of MedChem with @mirazrahman.bsky.social at @kingscollegelondon.bsky.social on generating new efflux-resistant TKIs for CML treatment. πŸ‘Š

pubs.acs.org/doi/10.1021/...

26.11.2025 20:32 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image Post image

Well done to Drs Hyun Park and Aaron Goff from @biochembiomeduos.bsky.social @bsmsmedschool.bsky.social @sussexbcr.bsky.social who’ve both had abstracts accepted for presentation at the @ash.hematology.org 2025 meeting in December, and been awarded ASH achievement awards!

See you in Orlando! πŸ‡ΊπŸ‡Έ

07.11.2025 16:29 πŸ‘ 3 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0
Post image

Tonight was the U.K. premier of β€˜Goodbye Breasts’ written, directed and produced by Joanne Callaghan, documenting her remarkable breast cancer story. A must see!
@gdsc-sussex.bsky.social
@sussexcancer.org
@sussexbcr.bsky.social
sussexcancerfund.co.uk

11.11.2025 22:33 πŸ‘ 2 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0

Looking for a PhD on stem cells, microenvironment and gene regulation/alternative splicing. Join us for this great project with @whatchamacaulay.bsky.social

21.10.2025 15:29 πŸ‘ 7 πŸ” 5 πŸ’¬ 0 πŸ“Œ 0

Prof. Tim Humphrey and Dr. Rhys Morgan both gave talks at the recent "Science CafΓ©" hosted by the Sussex Cancer Fund in partnership with the Macmillan Horizon Centre. A fabulous series of short talks for anyone interested in hearing a little more about the latest developments in cancer research.

30.09.2025 14:41 πŸ‘ 2 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0

🍾New promotion in the network! πŸŽ‰

A massive congratulations to Simon Mitchell @mitchell.science from @bsmsmedschool.bsky.social recently promoted to Professor!

Simon has transformed the Cancer Research portfolio at Sussex with his work at the Sussex BCR and the creation of @sussexcancer.org

πŸ™ŒπŸ‘ŠπŸ‘

11.10.2025 15:47 πŸ‘ 2 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Post image

Excited to have been promoted to Professor in Cancer Systems Biology at @bsmsmedschool.bsky.social, University of Sussex, @uniofbrighton.bsky.social

09.10.2025 20:20 πŸ‘ 11 πŸ” 3 πŸ’¬ 2 πŸ“Œ 1
Preview
(MRC DTP) Corrupting the roots: How leukaemia reshapes its ancestors at The University of Manchester on FindAPhD.com PhD Project - (MRC DTP) Corrupting the roots: How leukaemia reshapes its ancestors at The University of Manchester, listed on FindAPhD.com

Many cancers begin as precancerous conditions. But what happens when these early cells coexist with a full-blown tumour?

Join us for an MRC funded PhD studentship exploring how primary cancers influence the evolution of precancerous cells.

www.findaphd.com/phds/project...

10.10.2025 09:15 πŸ‘ 2 πŸ” 2 πŸ’¬ 1 πŸ“Œ 0

πŸ’°New funding updateπŸ’°

Congratulations @rhysmorganlab.bsky.social in @biochembiomeduos.bsky.social for obtaining funding from @bloodcanceruk.bsky.social to target abnormal cell signalling mechanisms in AML.

This is now 1 of 6 active Blood Cancer UK grants in our growing network at Sussex. πŸ‘Š πŸ”¬πŸ§¬πŸ₯ΌπŸ©Έ

07.10.2025 06:53 πŸ‘ 4 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0

Very grateful to have been awarded our first @bloodcanceruk.bsky.social research grant over the summer for our work targeting aberrant Wnt/Ξ²-catenin signalling in acute myeloid leukaemia (AML).

Our new project headed by Dr Wagstaff begins Oct 1st developing new ways to target oncogenic Ξ²-catenin πŸ‘Š

30.09.2025 15:06 πŸ‘ 11 πŸ” 2 πŸ’¬ 2 πŸ“Œ 1
Post image

Delighted to wave the flag for @gdsc-sussex.bsky.social
@sussexcancer.org
@sussexbcr.bsky.social
sussexcancerfund.co.uk together with Rhys Morgan at the Science Cafe, MacMillan Horizon centre today. Thanks to Rebecca Herbertson and Stephen Robinson for organizing.
@rhysmorganlab.bsky.social

29.09.2025 20:26 πŸ‘ 6 πŸ” 1 πŸ’¬ 0 πŸ“Œ 1

Our Co-Directors Prof @chrispepper68.bsky.social and Dr @rhysmorganlab.bsky.social explain the mission and vision for the Sussex Blood Cancer Research network.

@sussexcancer.org @bsmsmedschool.bsky.social @biochembiomeduos.bsky.social

23.09.2025 16:17 πŸ‘ 5 πŸ” 5 πŸ’¬ 0 πŸ“Œ 0
Prof Chris Pepper and Dr Rhys Morgan - Sussex Blood Cancer Research
Prof Chris Pepper and Dr Rhys Morgan - Sussex Blood Cancer Research YouTube video by Brighton and Sussex Medical School

πŸ’‘ How are #BSMS researchers working to change the future of blood cancer?
Prof Chris Pepper and Dr Rhys Morgan share their journey, their goals and why this research matters.
β–ΆWatch here: www.youtube.com/watch?v=0EwD...
@sussexbcr.bsky.social #MedicalResearch

23.09.2025 07:33 πŸ‘ 5 πŸ” 2 πŸ’¬ 0 πŸ“Œ 1